Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
William K. Heiden | Director | 2025-08-20 | 49,500 | $1.49 | $73.76kBuy |
William K. Heiden | Director | 2025-08-19 | 50,500 | $1.52 | $76.76kBuy |
Stephen L. Eck | Chief Medical Officer | 2025-02-15 | 4,942 | $2.56 | $12.65kSell |
Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-15 | 5,147 | $2.56 | $13.18kSell |
James Karrels | SVP CFO and Secretary | 2025-02-15 | 5,790 | $2.56 | $14.82kSell |
Thomas Spitznagel | Sr VP Technical Ops | 2025-02-15 | 5,520 | $2.56 | $14.13kSell |
Beth Ann Smith | VP Controller Treasurer | 2025-02-15 | 423 | $2.56 | $1.08kSell |
Eric Blasius Risser | Chief Operating Officer | 2025-02-15 | 6,433 | $2.56 | $16.47kSell |
Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-08 | 3,475 | $2.60 | $9.04kSell |
Stephen L. Eck | Chief Medical Officer | 2025-02-08 | 3,312 | $2.60 | $8.61kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Target N. V. Biotech | 15.71% | 9,929,963 | $15.49M | Insider |
Bellevue Group Ag | 15.69% | 9,919,992 | $15.48M | Institution |
Armistice Capital LLC | 9.43% | 5,960,000 | $9.30M | Institution |
Vanguard Group Inc | 6.67% | 4,213,114 | $6.57M | Institution |
Wasatch Advisors LP | 5.14% | 3,251,022 | $5.07M | Institution |
Frazier Life Sciences Management LP | 5.02% | 3,175,665 | $4.95M | Institution |
Acadian Asset Management LLC | 3.94% | 2,491,703 | $3.89M | Institution |
Tpg Group Holdings Sbs Advisors Inc | 3.49% | 2,208,762 | $3.45M | Insider |
Scott Koenig | 3.37% | 2,128,919 | $3.32M | Insider |
Millennium Management LLC | 3.19% | 2,015,864 | $3.14M | Institution |